About Bayer’s Dermatology unit

Passion for Dermatology

Bayer’s Dermatology unit is dedicated to provide innovative solutions for skin diseases. The global specialist has a successful track record in the development, manufacturing and marketing of innovative prescription drug products for the treatment of severe skin diseases.

Dermatology was also a pioneer in the development of locally applicable corticosteroid treatments. As part of Bayer HealthCare with commercial operations all around the globe, the unit offers a broad spectrum of proven, top-quality products to treat acne, rosacea, eczema, psoriasis, hemorrhoids and fungal infections.

In 2010 - with more than 700 employees worldwide – Bayer’s Dermatology unit reached sales of €300 million. It is headed by CEO and President Marc Lafeuille and headquartered in Berlin with its main production facility in Milan, Italy.



 

Key Facts

Headquarters Berlin, Germany
Staff (2010) About 700
Sales (2010) 306 € Mill.
Key countries Austria, Brazil, France, Germany, Italy, Japan, Mexico, Poland, Portugal, Russia, Spain, Turkey, USA

 

Global Management Structure

President & Global Head of Dermatology Marc Lafeuille
Finance & Administration Dr. Alexander Henrici
Commercial Operations Dr. Bernhard Schefter
Law & Patents Ulf Zimmerling
Global Development Dr. Eugene O'Keefe
Business Development Dr. Lilian Vakalopoulou
Global Strategic Marketing Daniela Chuayre Della Valle
Corporate Human Resources Quilco Hasemann
Corporate Communications Yvonne Moeller

© Intendis GmbH